Publication:
sLea and sLex expression in colorectal cancer: implications for tumourigenesis and disease prognosis

Simple item page
dc.contributor.authorVillar Portela, Susana
dc.contributor.authorVázquez Martín, Cristina
dc.contributor.authorMuinelo Romay, Laura
dc.contributor.authorCuevas, Elisa
dc.contributor.authorGil Martín, Emilio
dc.contributor.authorFernández Briera, Almudena
dc.date.accessioned2016-04-29T15:06:50Z
dc.date.available2016-04-29T15:06:50Z
dc.date.issued2011
dc.description.abstractThe glycoconjugates expressed by cancer cells frequently contain sialylated oligosaccharide chains. Among these oligosaccharides the sialyl Lewis a (sLea) and sialyl Lewis x (sLex) antigens are found to be overexpressed in tumours of different origin. The current study assesses sLea and sLex expression in different colorectal specimens in order to establish the correlation of these biomarkers with both malignant transformation of colorectal mucosa and the progression of colorectal cancer (CRC). Healthy disease-free and inflammatory mucosa specimens showed no presence of the antigens. sLea was expressed in 6.7% of the healthy tissue from CRC patients, in 20.8% of the adenomas, and in 33.3% and 42.6% of the transitional tissue and tumour tissue, respectively. sLex expression was observed in 6.7% of the healthy tissue from CRC patients, in 27.0% of the adenomas, and in 25.6% and 74.8% of the transitional and the tumour tissue, respectively. The expression of the sLea and sLex antigens was correlated in adenomas, as well as in healthy and tumour tissue from CRC. Moreover, the high expression of sLex in adenomas was correlated with a high degree of dysplasia (p=0.042). Finally, the survival analysis suggested that sLea expression may be a prognostic factor for predicting disease-free survival in colorectal cancer (p=0.012).es
dc.formatapplication/pdfes
dc.format.extent12es
dc.identifier.issn1699-5848
dc.identifier.issn0213-3911
dc.identifier.urihttp://hdl.handle.net/10201/49446
dc.languageenges
dc.publisherF. Hernández y J.F. Madrid. Murcia: Universidad de Murcia, Departamento de Biología Celular e Histología.es
dc.relation.ispartofHistology and histopathology, Vol. 26, nº10 (2011)es
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectSialyl Lewis aes
dc.subjectSialyl Lewis xes
dc.subjectColorectal canceres
dc.subject.other616 - Patología. Medicina clínica. Oncologíaes
dc.titlesLea and sLex expression in colorectal cancer: implications for tumourigenesis and disease prognosises
dc.typeinfo:eu-repo/semantics/articlees
dspace.entity.typePublicationes
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Villar-Portela-26-1305-1316-2011.pdf
Size:
1.58 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.35 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Histology and histopathology Vol.26,nº10 (2011)